• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH MED-EL MAESTRO COCHLEAR IMPLANT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH MED-EL MAESTRO COCHLEAR IMPLANT SYSTEM Back to Search Results
Model Number MI1000 MED-EL CONCERT
Device Problems Device Operates Differently Than Expected (2913); Output Problem (3005)
Patient Problems Failure of Implant (1924); Tinnitus (2103)
Event Type  Injury  
Manufacturer Narrative
The device has not been explanted.If it should be explanted, it is to be returned to the manufacturer for evaluation.When available, a device failure analysis will be submitted as a follow up report.
 
Event Description
In (b)(6) 2017 the user reported to have a very high tinnitus.In situ testing at this moment showed all channels are ok.In (b)(6) 2017 the tinnitus got worse.Latest in situ testing in (b)(6) 2017 showed 9 channels with high impedance and 2 channels involved in a short circuit.Re-implantation is considered.
 
Manufacturer Narrative
Conclusion: according to the information received, the recipient suffers from tinnitus, which is a known undesired side effect of cochlear implantation, and gradual decline in hearing performance.Additionally, diagnostic imaging shows one basal electrode contact outside the cochlea.Recent in situ measurements indicate a possible damage to the active electrode likely caused by minute device mobility.However, to determine an exact root cause a device investigation of the explanted device is necessary.Re-implantation is considered but no date has been scheduled yet.
 
Event Description
In (b)(6) 2017 the user reported to have a tinnitus, which is also present without wearing the external device.In situ testing at that moment showed a functional device.In (b)(6) 2017, the tinnitus got worse.The user noticed a gradual decrease in hearing performance with the device.Re-implantation is considered but no date has been scheduled yet.
 
Manufacturer Narrative
Conclusion: according to the information received, the recipient suffers from tinnitus, which is a known undesired side effect of cochlear implantation, and gradual decline in hearing performance.Additionally, diagnostic imaging shows one basal electrode contact outside the cochlea.Recent in situ measurements indicate a possible damage to the active electrode likely caused by minute device mobility.However, to determine an exact root cause a device investigation of the explanted device is necessary.Re-implantation is considered but no date has been scheduled yet.As per additional information received the recipient was explanted and re-implanted on the contralateral site.However the device has not been received for investigation.The above mentioned results still apply.If the device is received in the future, the case will be re-opened and the device investigated.This is a final report.
 
Event Description
In (b)(6) 2017 the user reported to have a tinnitus, which is also present without wearing the external device.In situ testing at that moment showed a functional device.In (b)(6) 2017, the tinnitus got worse.The user noticed a gradual decrease in hearing performance with the device.The user has been reimplanted on the contralateral side.
 
Manufacturer Narrative
Conclusion: damage to the active electrode, likely caused by minute device mobility, was determined to have led to device failure over time.Other damaged found during investigation are attributable to the explantation surgery.In addition the recipient suffers from tinnitus, which is a known undesired side effect of cochlear implantation and is also present without the use of the external device.Furthermore diagnostic imaging shows one basal electrode contact outside the cochlea.The problems given in the recipient report appear to match the damage found.This is a final report.
 
Event Description
In (b)(6) 2017 the user reported to have a tinnitus, which is also present without wearing the external device.In (b)(6) 2017, the tinnitus got worse.The user noticed a gradual decrease in hearing performance with the device.The user was explanted of the device on (b)(6) 2018.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MED-EL MAESTRO COCHLEAR IMPLANT SYSTEM
Type of Device
COCHLEAR IMPLANT
Manufacturer (Section D)
MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
innsbruck
AU 
Manufacturer Contact
laura simonotti
fuerstenweg 77a
innsbruck 6020
AU   6020
57788
MDR Report Key7137654
MDR Text Key95817049
Report Number9710014-2017-001083
Device Sequence Number1
Product Code MCM
Combination Product (y/n)N
Reporter Country CodeAR
PMA/PMN Number
P000025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 10/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMI1000 MED-EL CONCERT
Other Device ID Number(01) 09008737062682
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/31/2019
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/19/2017
Initial Date FDA Received12/21/2017
Supplement Dates Manufacturer Received12/19/2017
12/19/2017
12/19/2017
Supplement Dates FDA Received02/15/2018
05/16/2019
10/03/2019
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-